The treatment of advanced ovarian carcinoma (I): Clinical variables associated with prognosis
- 31 July 1988
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 30 (3), 347-358
- https://doi.org/10.1016/0090-8258(88)90249-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cytoreductive surgery in ovarian carcinoma: Feasibility and morbidityInternational Journal of Gynecology & Obstetrics, 1987
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinomaGynecologic Oncology, 1985
- Spontaneous mutation to chemotherapy resistance: implications of the Goldie-Coldman model for the management of ovarian cancer.Journal of Clinical Oncology, 1984
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- The Role of the Abdominal Radical Tumor Reduction Procedure (A.R.Tu.R.) in the Treatment of Ovarian CancerPublished by Springer Science and Business Media LLC ,1984
- Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1983
- Chemotherapy in advanced diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Combination chemotherapy of advanced ovarian cancer with cyclophosphamide (C), hexamethylmelamine (H), adriamycin (A) and diamminedichloroplatinum (D) — The “CHAD” regimenGynecologic Oncology, 1980
- Intensive Surgical and Chemotherapeutic Management of Advanced Ovarian CancerSurgical Clinics of North America, 1978